FDA Investigator Matthew R Dionne

Matthew R Dionne has inspections in 5 countries as of 16 Nov 2023. Matthew R Dionne has collaborated with a combinined 3822 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
70
Last Inspection Date:
16 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Ireland, Canada, Italy, France
Co-Investigator(s):
Adetutu M Gidado, Alan P Kurtzberg, Amanda S Zorn, Ana C Lazo, Anastasia M Shields, Andrea J Schmidt, Andrea S Heise, Andrew M Kolenc, Anita R Michael, Anthony J Lagreca, Arie C Menachem, Ashleigh P Barkans, Ashleigh P Wodushek, Azotearc, Azza Talaat, Betty K Baxter, Brenda W Uratani, PhD, Brent W Higgs, Brian D Nicholson, Bryan A Galvez, Bryce A Hammer, Carl A Anderson, Carla R Hinz, Carlos Chavez, Caroline H Le, Carrie E Jolly, Carterm, Chelsea N Sealey, Christina A Mayer, Christine I Shaw, Christine L Williams, Christopher M Jenner, Christopher R Czajka, Daniel J Lahar, Daniel Pst Laurent, David A Gonzalez, Deborah S Hammond, Debra L Curtis, Denicia L Hernandez, Deyaa Shaheen, Dianna D Wardlow Dotter, Donald L Lech, Dongping Dai, PhD, Doris M Sachanandani, Dr. Carmelo Rosa, Dr. Gang Wang, PhD, Duc Minh H Nguyen, Dustin M James, Edith M Gonzalez, Elaine G Stewart, Elisa J Beard, Elizabeth D Gonzales, Elizabeth Ll Edwards, Elvin R Smith, Eric S Myskowski, Erik W Burrows, Erika V Butler, Felix J Marrero, Frank L Cordova, Frederic W French, III, Frederick L Fricke, Gary C Pecic, Genoula K Ryan, Gerard T Schneider, Ginger M Sykes, Grace E Mcnally, Hanna L Potter, Haroon Vohra (NMI), Holly L Miller, Ian M Carrico, Isabel Y Espinosa, Isaiah D Isakson, Jacqueline Mdiaz Albertini, James A Lane, James D Bradley, James D Romero, James L Dunnie, Jr, James R Montero, Jamie L Dion, Jamie L Port, Janet Pulver, Jennifer A Baker, Jennifer A Robinson, Jennifer D Hollstrom, Jennifer L Wolfe, Jennifer R Mathern, Jessica M Ector, Jessie E Morris, Jin M Kim, Jonathan R Campos, Jose E Melendez, DDC, Jose M Cayuela, Jose R Hernandez, Juan A Morales, Julianne C Mccullough, Justin H Erickson, Justin R Carr, Karen A Wolnik, Karen E D'orazio, Karen G Hirshfield, Katherine Szestypalow, Kathleen S Tormey, Kathryn M Mogen, Keith C Littrell, Kelly D Moore, Kelly Lancelot, Kenneth V Miller, Kent C Faul, Kevin D Kallander, Kim Lthomas Cruse, Kimberley A Hoefen, Kimetha A King, Kristen D Evans, Kristen E Szenderski, Larisa E Pavlick, Larry Gehring, Laura B Kennedy, Laura L Staples, Lavender M Huskey, Lewis K Antwi, Linda F Murphy, Linda M Cheny, Lisa Shin, Lori A Carr, Luella J Rossi, Manuel A Moreno, Marc A Jackson, Jr, Marcus F Yambot, Margaret M Annes, Marianela Aponte Cruz, Marie Bbuen Bigornia, Marijo B Kambere, PhD, Marion W Nadeau, Marsha L Mccauley, Martina E Lagrange, Mary F Bodick, Matthew A Johnson, Matthew A Kozler, Matthew J Hansen, Matthew M Vernon, Melissa F Chauvin, Melissa J Garcia, Metitia M Gramby, Michael A Charles, Michael E Maselli, Michael J Kuchta, Michael Kuchta, Michael R Goga, Mihaly S Ligmond, Morie Alpha, Mra Davism, Mra Mcculloughj, Nalini D Lebzelter, Nancy G Schmidt, Nathan M Jornod, Nathan R Moon, Nayan J Patel, Neira Acevedo Ramos, Nicole J Clausen, Parul M Patel, Patricia A Brown, Patricia A Cortez, Patricia A Maestas, Patricia Brown, Patricia D Stahnke, Paul J Teitell, Paul Z Balcer, Rafael H Ortiz, Rajiv R Srivastava, Rebecca H Lee, Richard J Friedman, Ricki A Chase, Ricki Achase Off, Robert M Tillman, Robert Sharpnack, Rosa J Motta, Rose J Motta, Rose Xu, Rowena S Nguyen, Rozelle G Smith, Russell J Glapion, Saied A Asbagh, Saleem A Akhtar, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Shererk, Simone E Pitts, Siobhan A Gallagher, Siobhan G Taylor, Sripal R Mada, PhD, State Agency, Stefanie R Cook, Stephen T Hansen, Steven C Madzo, Susan M Jackson, Tamara J Umscheid, Tamara L Setzer, Teena H Aiken, Tenzin Jangchup, Terri L Thomas, Thai T Duong, Theressa B Smith, Thomas V Anderson, Toni L Morales, Trevor R Beach, Trinidad D Barreras, Truong Xuan Nguyen (Andy), Uduak M Inokon, Vicky L Cruz, Wayne W Grundstrom, Wdouglas Rowe, William A Lanier, William D Boden, Yiyue Zhang (nmi), PhD, Yong Hu, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm

Matthew R Dionne's Documents

Publish Date Document Type Title
January, 2020 FDA 483 Response OraLabs, Inc - Form 483R, 2020-01-10
February, 2011 FDA 483 Fresenius Medical Care North America - Form 483, 2011-02-04
March, 2013 FDA 483 College Pharmacy, Inc. - Form 483, 2013-03-15
October, 2008 FDA 483 Sandoz Incorporated - Form 483, 2008-10-08
April, 2010 FDA 483 Upsher-Smith Laboratories, LLC - Form 483, 2010-04-30
January, 2011 FDA 483 Actavis Laboratories UT, Inc. - Form 483, 2011-11-04
October, 2008 FDA 483 Response Sandoz Incorporated - Form 483R, 2008-11-06
June, 2009 FDA 483 Genesis Alkali Wyoming, LP - Form 483, 2009-06-24
January, 2010 FDA 483 Nelson Laboratories, LLC - Form 483, 2010-01-08
February, 2009 FDA 483 Aliri USA Inc. - Form 483, 2009-02-12
October, 2011 EIR Church & Dwight Co., Inc. - EIR, 2011-10-25
February, 2009 EIR Aliri USA Inc. - EIR, 2009-02-12
March, 2012 FDA 483 Nelson Laboratories, LLC - Form 483, 2012-03-09
January, 2010 FDA 483 Ultradent Products, Inc. - Form 483, 2010-01-15
October, 2009 FDA 483 UnitDrugCo., LLC - Form 483, 2009-10-15
October, 2010 FDA 483 Sample Solutions, L.L.C. - Form 483, 2010-10-21
June, 2010 FDA 483 Regenerative Sciences, LLC - Form 483, 2010-06-16
November, 2009 FDA 483 BioCentric Labs Inc - Form 483, 2009-11-13
January, 2020 EIR OraLabs, Inc - EIR, 2020-01-23
April, 2010 FDA 483 Septodont, Inc - Form 483, 2010-04-14
October, 2011 FDA 483 Genesis Alkali Wyoming, LP - Form 483, 2011-10-21
October, 2008 EIR Sandoz Incorporated - EIR, 2008-10-08
January, 2020 FDA 483 OraLabs, Inc - Form 483, 2010-08-11
March, 2012 EIR Nelson Laboratories, LLC - EIR, 2012-03-09
May, 2009 FDA 483 Clarcon Biological Chemistry Laboratory Inc. - Form 483, 2009-05-04
January, 2020 FDA 483 OraLabs, Inc - Form 483, 2020-01-10

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more